TOWSON, MD – September 18, 2026 (STL.News) Remedi SeniorCare Holding Corporation has agreed to pay more than $5.3 million to resolve federal allegations that the long-term-care pharmacy billed Medicare and Medicaid for prescription drugs dispensed to assisted-living residents without valid prescriptions, marking the company’s second significant False Claims Act settlement with the federal government.
The U.S. Department of Justice announced the latest settlement Thursday, Sept. 17, saying the alleged conduct occurred over more than six years, from Jan. 1, 2015, through March 31, 2021.
Remedi, headquartered in Towson, Maryland, did not admit liability. The Justice Department emphasized that the claims resolved through the settlement are allegations and that it has not determined liability.
A review by STL.News of the underlying 24-page consent judgment and settlement agreement provides considerably more detail than the government’s announcement, including the precise financial obligation, payments to state Medicaid programs, the whistleblowers’ share of the recovery and provisions tied to Remedi’s financial condition.
Under the federal agreement, Remedi consented to a judgment of $5,389,780, all characterized as restitution, plus interest of 4.5% annually beginning May 6, 2026.
Remedi separately agreed to pay $110,220, also characterized as restitution, plus 4.5% interest, to participating state Medicaid programs under...
The Justice Department filed a complaint under the False Claims Act against Capstone Diagnostics executives Jay Johnson and Austin Whiles, alleging they orchestrated two genetic testing schemes th...